P59.3
Neonatal jaundice from breast milk inhibitor
Clinical Classification Guidelines
Medical Intelligence & Overview
Neonatal jaundice from breast milk inhibitor (ICD-10 Code P59.3) is a condition that affects newborns, leading to yellowing of the skin and eyes due to elevated bilirubin levels. This type of jaundice occurs because certain substances in some breast milk can interfere with the baby's ability to process and eliminate bilirubin. While common in newborns, it requires careful monitoring and management to prevent potential complications.
Causes & Symptoms
Clinical Causes: Presence of specific substances in breast milk that inhibit bilirubin conjugation Genetic factors influencing bilirubin metabolism Immature liver function in newborns Increased breakdown of red blood cells leading to excess bilirubin
Key Symptoms: Yellowing of the skin and the sclera (white part of the eyes) Lethargy or decreased activity levels Poor feeding or difficulty feeding Irritability or fussiness Dark-colored urine Pale or clay-colored stools
Diagnostic & Treatment
Diagnosis Path: Diagnosis usually involves physical examination and measuring bilirubin levels in the blood or through skin assessment. Healthcare providers may perform additional tests to rule out other causes of neonatal jaundice and confirm if breast milk contains inhibitory substances. Monitoring the baby's weight, feeding patterns, and bilirubin trends helps guide diagnosis and management decisions.
Treatment Protocols: Managing this type of neonatal jaundice typically involves the following approaches:
Clinical Advice & FAQs
Billing Guidance
Is P59.3 a billable ICD-10 code?
Yes, P59.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P59.3?
Clinical documentation must specify the nature of Neonatal jaundice from breast milk inhibitor and any associated comorbidities for accurate reporting.
Cite this Clinical Reference